The double action of TGF-β1 on Smad-dependent and Smad-independent signaling is relevant when considering the pathophysiology of cognitive decline in AD and the selective impairment of Smad signaling detected in AD brains [46]. The gene discussed is TGFB1; the disease is Alzheimer disease.